Difference between revisions of "Contexts"
Jump to navigation
Jump to search
m (→Untreated) |
m |
||
| Line 5: | Line 5: | ||
==Locally advanced== | ==Locally advanced== | ||
==Advanced== | ==Advanced== | ||
| + | ==Advanced or metastatic== | ||
==Metastatic== | ==Metastatic== | ||
==Relapsed or refractory== | ==Relapsed or refractory== | ||
Latest revision as of 01:45, 12 April 2021
The purpose of this page is to define treatment contexts used in the HemOnc ontology; it is not for other purposes at this time.
FDA indication language
Early stage
Locally advanced
Advanced
Advanced or metastatic
Metastatic
Relapsed or refractory
Untreated
AKA: Newly diagnosed